Welcome to our dedicated page for AMEREN SEC filings (Ticker: AEE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMEREN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMEREN's regulatory disclosures and financial reporting.
Shawn E. Schukar, an officer of Ameren Corporation (AEE), reported a change in beneficial ownership dated 08/19/2025. The filing shows an indirect holding of 3,101 share equivalents in the Ameren Savings Investment Plan as of July 31, 2025. On 08/19/2025 the reporting person disposed of 796 shares of Ameren common stock (transaction code G) at a recorded price of $0. Following the reported transaction, the reporting person beneficially owned 56,816 shares, which includes 126 accrued dividend equivalents from restricted stock units under the 2022 Omnibus Incentive Compensation Plan. The form was signed by an attorney-in-fact on 08/20/2025.
T. Rowe Price Investment Management, Inc. reports a material passive stake in Ameren Corporation, holding 14,362,684 shares, equal to 5.2% of the common stock. The filer discloses sole voting power for 13,437,982 shares and sole dispositive power for all 14,362,684 shares, with no shared voting or dispositive authority. The Schedule 13G classification and the filer’s certification indicate these shares are held in the ordinary course of business and are not reported as intended to change or influence control. The filing clarifies ownership magnitude and voting authority without announcing any change in control.
Transaction summary: Michael L. Moehn, Sr Executive VP & CFO of Ameren Corporation (AEE), reported a sale of 6,500 shares of Ameren common stock on 08/01/2025 at $102.54 per share. Following the reported transaction, Mr. Moehn beneficially owns 204,879 shares directly. He also holds 5,147 share equivalents indirectly in the Ameren Savings Investment Plan unitized stock fund as of 07/31/2025.
Filing notes: The Form 4 was dated and signed by Jonathan T. Shade as attorney-in-fact on 08/05/2025. The filing states that the reported direct total includes 611 accrued dividend equivalents acquired in Q2 2025 pursuant to dividend reinvestment of restricted stock units under the issuer's 2022 Omnibus Incentive Compensation Plan. No derivative transactions were reported on this form.
Ameren Corp. (AEE) filed a Form 144 covering a planned insider sale of 6,500 common shares through Fidelity Brokerage Services on or about 01 Aug 2025. At the filing’s reference price, the block is valued at ≈ $666,510. The shares stem from restricted-stock vesting on 01 Mar 2025 and were received as compensation, not purchased for cash.
The seller, Michael Moehn (address disclosed), previously sold an identical 6,500-share lot on 20 May 2025 for $641,030. Ameren reports 270,278,917 shares outstanding, so the proposed sale represents roughly 0.0024 % of the float—an immaterial level for dilution and ownership concentration. The filer affirms no knowledge of undisclosed adverse information and, if applicable, compliance with Rule 10b5-1 trading-plan requirements.
Given the limited size, routine compensation origin and absence of other transactional details, the notice appears administrative with negligible capital-market impact.